Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 7, 2012, Pages 560-573

  Beaudry, Jacqueline L ^a,b   Riddell, Michael C ^a,b  

^a YORK UNIVERSITY   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

Glucocorticoids; Intermittent stress; Pancreatic cell pathology; Partial pancreatectomy; Physical activity; Type 2 diabetes mellitus

Indexed keywords

GLUCOCORTICOID;

CORTICOSTEROID BLOOD LEVEL; EXERCISE; HUMAN; IMMOBILIZATION; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; STRESS;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EXERCISE; GLUCOCORTICOIDS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MOTOR ACTIVITY; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84867045026     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2310     Document Type: Review

References (112)

1. Kim A, Miller K, Jo J, Kilimnik G, Wojcik P, Hara M. Islet architecture: a comparative study. Islets 2009; 1(2): 129-136.
2. Lansang MC, Hustak LK. Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them. Cleve Clin J Med 2011; 78(11): 748-756.
3. Conn JW, Louis LH, Wheeler CE. Production of temporary diabetes mellitus in man with pituitary adrenocorticotropic hormone; relation to uric acid metabolism. J Lab Clin Med 1948; 33(6): 651-661.
4. Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes 2002; 51(Suppl 1): S271-S283.
5. Grodsky GM, Batts AA, Bennett LL, Vcella C, McWilliams NB, Smith DF. Effects of carbohydrates on secretion of insulin from isolated rat pancreas. Am J Physiol 1963; 205: 638-644.
6. English PJ, Coughlin SR, Hayden K, Malik IA, Wilding JP. Plasma adiponectin increases postprandially in obese, but not in lean, subjects. Obes Res 2003; 11(7): 839-844.
7. Grodsky GM, Curry D, Landahl H, Bennett L. Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system. Acta Diabetol Lat 1969; 6(Suppl 1): 554-578.
8. Seino S, Shibasaki T, Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest 2011; 121(6): 2118-2125.
9. Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001; 86(9): 4047-4058.
10. Topp BG, Atkinson LL, Finegood DT. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. Am J Physiol Endocrinol Metab 2007; 293(6): E1730-E1735.
11. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52(1): 102-110.
12. Porte D Jr. Normal physiology and phenotypic characterization of beta-cell function in subjects at risk for non-insulin-dependent diabetes mellitus. Diabet Med 1996; 13(9 Suppl 6): S25-S32.
13. Polonsky KS. Dynamics of insulin secretion in obesity and diabetes. Int J Obes Relat Metab Disord 2000; 24(Suppl 2): S29-S31.
14. Vinik A. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Clin Ther 2007; 29(Spec No): 1236-1253.
15. Finegood DT, McArthur MD, Kojwang D, et al. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001; 50(5): 1021-1029.
16. Butler AE, Janson J, Soeller WC, Butler PC. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003; 52(9): 2304-2314.
17. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10(Suppl 4): 32-42.
18. Hanley SC, Austin E, Assouline-Thomas B, et al. β-cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 2010; 151(4): 1462-1472.
19. Park S, Hong SM, Lee JE, Sung SR. Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats. J Appl Physiol 2007; 103(5): 1764-1771.
20. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53(Suppl 3): S16-S21.
21. Sachdeva MM, Stoffers DA. Minireview: meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. Mol Endocrinol 2009; 23(6): 747-758.
22. Lipsett M, Finegood DT. Beta-cell neogenesis during prolonged hyperglycemia in rats. Diabetes 2002; 51(6): 1834-1841.
23. Demeterco C, Hao E, Lee SH, Itkin-Ansari P, Levine F. Adult human beta-cell neogenesis? Diabetes Obes Metab 2009; 11(Suppl 4): 46-53.
24. Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992; 326(1): 22-29.
25. Perreault L, Bergman BC, Hunerdosse DM, Playdon MC, Eckel RH. Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans. Obesity (Silver Spring) 2010; 18(8):1524-1531.
26. van Raalte DH, Diamant M. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res Clin Pract 2011; 93(Suppl 1): S37-S46.
27. Prentki M, Corkey BE. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 1996; 45(3): 273-283.
28. Bonner-Weir S. Beta-cell turnover: its assessment and implications. Diabetes 2001; 50(Suppl 1): S20-S24.
29. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444(7121): 840-846.
30. Jeschke MG, Boehning D. Endoplasmic reticulum stress and insulin resistance post-trauma: similarities to type 2 diabetes. J Cell Mol Med 2012; 16(3): 437-444.
31. McMahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 1988; 4(1): 17-30.
32. Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 2006; 8(4): 383-395.
33. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 2011; 60: 1500-1510.
34. Piroli GG, Grillo CA, Reznikov LR, et al. Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 2007; 85(2): 71-80.
35. Schacke H, Rehwinkel H, Asadullah K, Cato AC. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Exp Dermatol 2006; 15(8): 565-573.
36. van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 2009; 39(2): 81-93.
37. Vander Kooi BT, Onuma H, Oeser JK, et al. The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements. Mol Endocrinol 2005; 19(12): 3001-3022.
38. Bates HE, Sirek A, Kiraly MA, et al. Adaptation to intermittent stress promotes maintenance of beta-cell compensation: comparison with food restriction. Am J Physiol Endocrinol Metab 2008; 295(4): E947-E958.
39. Vranic M. Effects of cortisol in guinea pigs with normal and atrophic exocrine pancreas. Diabetes 1965; 14: 194-200.
40. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S. The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. Proc Natl Acad Sci U S A 1992; 89(13): 6035-6039.
41. D'souza AM, Beaudry JL, Szigiato AA, et al. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. Am J Physiol Gastrointest Liver Physiol 2012; 302(8): G850-G856.
42. Rafacho A, Cestari TM, Taboga SR, Boschero AC, Bosqueiro JR. High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets. Am J Physiol Endocrinol Metab 2009; 296(4): E681-E689.
43. Laybutt DR, Glandt M, Xu G, et al. Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 2003; 278(5): 2997-3005.
44. Gremlich S, Roduit R, Thorens B. Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids. J Biol Chem 1997; 272(6): 3216-3222.
45. Rafacho A, Ribeiro DL, Boschero AC, Taboga SR, Bosqueiro JR. Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats. Int J Exp Pathol 2008; 89(4): 264-275.
46. Rafacho A, Abrantes JL, Ribeiro DL, et al. Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats. Horm Metab Res 2011; 43(4): 275-281.
47. Shpilberg Y, Beaudry JL, D'Souza A, Campbell JE, Peckett A, Riddell MC. A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding. Dis Model Mech 2012, DOI: 10.1242/dmm.008912.
48. Holness MJ, Smith ND, Greenwood GK, Sugden MC. Interactive influences of peroxisome proliferator-activated receptor alpha activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. Diabetologia 2005; 48(10): 2062-2068.
49. Calabrese A, Zhang M, Serre-Beinier V, et al. Connexin 36 controls synchronization of Ca2+ oscillations and insulin secretion in MIN6 cells. Diabetes 2003; 52(2): 417-424.
50. Herve JC, Derangeon M, Sarrouilhe D, Giepmans BN, Bourmeyster N. Gap junctional channels are parts of multiprotein complexes. Biochim Biophys Acta 2011, DOI: 10.1016/j.bbamem.2011.12.009
51. Rafacho A, Roma LP, Taboga SR, Boschero AC, Bosqueiro JR. Dexamethasone-induced insulin resistance is associated with increased connexin 36 mRNA and protein expression in pancreatic rat islets. Can J Physiol Pharmacol 2007; 85(5): 536-545.
52. Kelly C, Parke HG, McCluskey JT, Flatt PR, McClenaghan NH. The role of glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell function in heterotypic pseudoislets. Diabetes Metab Res Rev 2010; 26(7): 525-533.
53. Jeong IK, Oh SH, Kim BJ, et al. The effects of dexamethasone on insulin release and biosynthesis are dependent on the dose and duration of treatment. Diabetes Res Clin Pract 2001; 51(3): 163-171.
54. Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 1997; 99(3): 414-423.
55. Ullrich S, Zhang Y, Avram D, et al. Dexamethasone increases Na+/K+ ATPase activity in insulin secreting cells through SGK1. Biochem Biophys Res Commun 2007; 352(3): 662-667.
56. Linssen MM, van Raalte DH, Toonen EJ, et al. Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells. Cell Signal 2011; 23(11): 1708-1715.
57. Ogawa A, Johnson JH, Ohneda M, et al. Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. J Clin Invest 1992; 90(2): 497-504.
58. Koizumi M, Yada T. Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic beta-cells. J Endocrinol 2008; 197(2): 221-229.
59. Wang ZL, Bennet WM, Wang RM, Ghatei MA, Bloom SR. Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats. Endocrinology 1994; 135(1): 200-206.
60. Davani B, Portwood N, Bryzgalova G, et al. Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes. Diabetes 2004; 53(Suppl 1): S51-S59.
61. van Raalte DH, Nofrate V, Bunck MC, et al. Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. Eur J Endocrinol 2010; 162(4): 729-735.
62. Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006; 54(9): 2765-2775.
63. Hansen KB, Vilsboll T, Bagger JI, Holst JJ, Knop FK. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. J Clin Endocrinol Metab 2010; 95(7): 3309-3317.
64. van Raalte DH, Brands M, van der Zijl NJ, et al. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia 2011; 54(8): 2103-2112.
65. Hoes JN, van der Goes MC, van Raalte DH, et al. Glucose tolerance, insulin sensitivity and beta-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids. Ann Rheum Dis 2011; 70(11): 1887-1894.
66. Willi SM, Kennedy A, Wallace P, Ganaway E, Rogers NL, Garvey WT. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. Diabetes 2002; 51(10): 2895-2902.
67. van Raalte DH, van Genugten RE, Linssen MM, Ouwens DM, Diamant M. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care 2011; 34(2): 412-417.
68. Bunck MC, Diamant M, Corner A, et al. One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 2009; 32(5): 762-768.
69. Shao S, Fang Z, Yu X, Zhang M. Transcription factors involved in glucose-stimulated insulin secretion of pancreatic beta cells. Biochem Biophys Res Commun 2009; 384(4): 401-404.
70. Gesina E, Tronche F, Herrera P, et al. Dissecting the role of glucocorticoids on pancreas development. Diabetes 2004; 53(9): 2322-2329.
71. Lantz KA, Kaestner KH. Winged-helix transcription factors and pancreatic development. Clin Sci (Lond) 2005; 108(3): 195-204.
72. Shen CN, Seckl JR, Slack JM, Tosh D. Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J 2003; 375(Pt 1): 41-50.
73. Arumugam R, Horowitz E, Lu D, et al. The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy. Endocrinology 2008; 149(11): 5401-5414.
74. Campbell JE, Rakhshani N, Fediuc S, Bruni S, Riddell MC. Voluntary wheel running initially increases adrenal sensitivity to adrenocorticotrophic hormone, which is attenuated with long-term training. J Appl Physiol 2009; 106(1): 66-72.
75. Bates HE, Kiraly MA, Yue JT, et al. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat-role of food intake and corticosterone. Metabolism 2007; 56(8): 1065-1075.
76. Kiraly MA, Bates HE, Yue JT, et al. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise. Metabolism 2007; 56(6): 732-744.
77. Duclos M, Corcuff JB, Pehourcq F, Tabarin A. Decreased pituitary sensitivity to glucocorticoids in endurance-trained men. Eur J Endocrinol 2001; 144(4): 363-368.
78. Droste SK, Chandramohan Y, Hill LE, Linthorst AC, Reul JM. Voluntary exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the adrenal level. Neuroendocrinology 2007; 86(1): 26-37.
79. Coutinho AE, Campbell JE, Fediuc S, Riddell MC. Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11beta-HSD1 in the Syrian hamster. J Appl Physiol 2006; 100(5): 1483-1488.
80. Campbell JE, Kiraly MA, Atkinson DJ, D'souza AM, Vranic M, Riddell MC. Regular exercise prevents the development of hyperglucocorticoidemia via adaptations in the brain and adrenal glands in male Zucker diabetic fatty rats. Am J Physiol Regul Integr Comp Physiol 2010; 299(1): R168-R176.
81. Heath GW, Gavin JR 3rd, Hinderliter JM, Hagberg JM, Bloomfield SA, Holloszy JO. Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity. J Appl Physiol 1983; 55(2): 512-517.
82. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393-403.
83. Nilsen V, Bakke PS, Gallefoss F. Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus-results from a randomised, controlled trial. BMC Public Health 2011; 11: 893.
84. Burr JF, Rowan CP, Jamnik VK, Riddell MC. The role of physical activity in type 2 diabetes prevention: physiological and practical perspectives. Phys Sportsmed 2010; 38(1): 72-82.
85. Christ CY, Hunt D, Hancock J, Garcia-Macedo R, Mandarino LJ, Ivy JL. Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats. J Appl Physiol 2002; 92(2): 736-744.
86. Etgen GJ Jr, Brozinick JT Jr, Kang HY, Ivy JL. Effects of exercise training on skeletal muscle glucose uptake and transport. Am J Physiol 1993; 264(3 Pt 1): C727-C733.
87. Goodyear LJ, Hirshman MF, Valyou PM, Horton ES. Glucose transporter number, function, and subcellular distribution in rat skeletal muscle after exercise training. Diabetes 1992; 41(9): 1091-1099.
88. Richter EA, Mikines KJ, Galbo H, Kiens B. Effect of exercise on insulin action in human skeletal muscle. J Appl Physiol 1989; 66(2): 876-885.
89. Krotkiewski M, Lonnroth P, Mandroukas K, et al. The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1985; 28(12): 881-890.
90. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236(6): E667-E677.
91. Dela F, von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 2004; 287(5): E1024-E1031.
92. Bock G, Dalla Man C, Campioni M, et al. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. Diabetes 2007; 56(4): 1113-1119.
93. Slentz CA, Tanner CJ, Bateman LA, et al. Effects of exercise training intensity on pancreatic beta-cell function. Diabetes Care 2009; 32(10): 1807-1811.
94. Zawalich W, Maturo S, Felig P. Influence of physical training on insulin release and glucose utilization by islet cells and liver glucokinase activity in the rat. Am J Physiol 1982; 243(6): E464-E469.
95. Galbo H, Hedeskov CJ, Capito K, Vinten J. The effect of physical training on insulin secretion of rat pancreatic islets. Acta Physiol Scand 1981; 111(1): 75-79.
96. Farrell PA, Caston AL, Rodd D, Engdahl J. Effect of training on insulin secretion from single pancreatic beta cells. Med Sci Sports Exerc 1992; 24(4): 426-433.
97. Fluckey JD, Kraemer WJ, Farrell PA. Pancreatic islet insulin secretion is increased after resistance exercise in rats. J Appl Physiol 1995; 79(4): 1100-1105.
98. Oliveira CA, Paiva MF, Mota CA, et al. Exercise at anaerobic threshold intensity and insulin secretion by isolated pancreatic islets of rats. Islets 2010; 2(4): 240-246.
99. Styrud J, Eriksson UJ, Grill V, Swenne I. Experimental intrauterine growth retardation in the rat causes a reduction of pancreatic B-cell mass, which persists into adulthood. Biol Neonate 2005; 88(2): 122-128.
100. Siebel AL, Mibus A, De Blasio MJ, et al. Improved lactational nutrition and postnatal growth ameliorates impairment of glucose tolerance by uteroplacental insufficiency in male rat offspring. Endocrinology 2008; 149(6): 3067-3076.
101. Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001; 50(10): 2279-2286.
102. Laker RC, Gallo LA, Wlodek ME, Siebel AL, Wadley GD, McConell GK. Short-term exercise training early in life restores deficits in pancreatic beta-cell mass associated with growth restriction in adult male rats. Am J Physiol Endocrinol Metab 2011; 301(5): E931-E940.
103. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 2005; 30(1): 1-10.
104. Kiraly MA, Bates HE, Kaniuk NA, et al. Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am J Physiol Endocrinol Metab 2008; 294(2): E271-E283.
105. Delghingaro-Augusto V, Decary S, Peyot ML, et al. Voluntary running exercise prevents beta-cell failure in susceptible islets of the Zucker diabetic fatty rat. Am J Physiol Endocrinol Metab 2012; 302(2): E254-E264.
106. Pold R, Jensen LS, Jessen N, et al. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 2005; 54(4): 928-934.
107. Kiraly MA, Campbell J, Park E, et al. Exercise maintains euglycemia in association with decreased activation of c-Jun NH2-terminal kinase and serine phosphorylation of IRS-1 in the liver of ZDF rats. Am J Physiol Endocrinol Metab 2010; 298(3): E671-E682.
108. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000; 275(12): 9047-9054.
109. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117(4): 1162-1172.
110. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286(3): 327-334.
111. Choi SB, Jang JS, Hong SM, Jun DW, Park S. Exercise and dexamethasone oppositely modulate beta-cell function and survival via independent pathways in 90% pancreatectomized rats. J Endocrinol 2006; 190(2): 471-482.
112. Choi SB, Jang JS, Park S. Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 2005; 146(11): 4786-4794.